Dinesh Thakur

The past few years have been rough of Indian pharma companies, what with the US FDA raking them over the coals over alleged manufacturing lapses and discrepancies.

SC declines lawsuits against drug regulators: Activist

Dinesh Thakur, who exposed dangerous practices in India's drugs industry in 2013, filed the public interest litigations, which include a suit that alleges that the current drugs law is "unconstitutional".

Pharma crusader Thakur takes India's drug regulators to court

Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.

Cannot comment on charges against Ranbaxy: Thakur

Dinesh Thakur, the Ranbaxy whistleblower, says he have no basis to comment on Daiichi Sankyo's decision to sue the Singh family for concealment and misrepresentation of data, as he left the company in 2005.

Malvinder Singh denies Daiichi's charges of wrongdoing

CNBC-TV18 executive editor Shereen Bhan and Archana Shukla reports that Malvinder Singh, while denying all wrong-doing at Ranbaxy, says that Daiichi took months to clinch the deal and the due diligence process was rigourously followed.

Ranbaxy whistleblower pockets $48.5mn for settlement

CNBC-TV18‘s Archana Shukla takes a closer look at Dinesh Thakur, the man who blew the whistle on Ranbaxy, and kicked off a legal battle that other generic drug makers will take notes from

Ranbaxy whistleblower Thakur richer by Rs 266cr; speaks out

Dinesh Thakur served as the whistleblower in this case and is the former Ranbaxy Director and Global Head, Research Information & Portfolio Management. Thakur is entitled to Rs 266 crore as the whistleblower in the case, the US Justice Department said.